- Home
- ZDGE vs OTLK Comparison
ZDGE vs OTLK Comparison
Compare ZDGE & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZDGE | OTLK |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | 55 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.5M | 38.7M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZDGE | OTLK |
|---|---|---|
| Price | $2.85 | $0.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 68.7K | ★ 1.1M |
| Earning Date | 03-12-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | ★ 73.85 | 55.91 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,398,000.00 | $8,146,123.00 |
| Revenue This Year | $3.27 | $1,726.70 |
| Revenue Next Year | $5.76 | $80.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.73 | $0.34 |
| 52 Week High | $4.70 | $3.39 |
Technical Indicators
Market Signals| Indicator | ZDGE | OTLK |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 35.08 |
| Support Level | $2.24 | N/A |
| Resistance Level | $3.43 | $0.46 |
| Average True Range (ATR) | 0.21 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 32.14 | 35.04 |
Price Performance
Historical ComparisonAbout ZDGE Zedge Inc. Class B
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.